Merck Millipore acquires rights for Biotest microbiology products
Merck Millipore now has exclusive rights to sell Biotest microbiology products in Australia and New Zealand.
In 2011, Merck Millipore acquired German company Biotest, an innovative industrial microbiology company with capabilities in ready-to-use media and hygiene monitoring. Its products are targeted at the pharmaceutical and food and beverage segments.
Biotest’s microbiology products, previously marketed by either of their two trading companies, Heipha and Hycon, are now exclusively available through Merck Millipore. Technical support for the products is also offered.
Australia–Vietnam collaborative research projects — applications open
Until 20 July, grant applications for projects in recycling and waste management, a sustainable...
AI and deep-tech research program receives $400K grant
A program designed to help scientists transform AI and deep-tech research into commercially...
Horizon Europe negotiations conclude
Once associated, Australian researchers and entities will be able to access Horizon Europe...
